Stocktoria
Neuronetics, Inc. STIM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-06-28
Neuronetics, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $149.2M | $74.9M | $71.3M | $65.2M | $55.3M |
| Gross profit | $72.3M | $54.2M | $51.7M | $49.7M | $43.7M |
| R&D expense | $6.6M | $12.8M | $9.5M | $9.3M | $7.9M |
| Operating income | -$31.4M | -$34.6M | -$30.6M | -$35.1M | -$27.6M |
| Interest expense | — | $7.3M | $5.4M | $4.3M | $4.0M |
| Net income | -$39.0M | -$43.7M | -$30.2M | -$37.2M | -$31.2M |
| EPS (diluted) | $-0.59 | $-1.38 | $-1.05 | $-1.38 | $-1.22 |
| Operating cash flow | -$20.4M | -$31.0M | -$32.0M | -$30.7M | -$28.0M |
| Cash & equivalents | $28.1M | $18.5M | $59.7M | $70.3M | $94.1M |
| Inventory | $4.3M | $4.2M | $8.1M | $8.9M | $6.6M |
| Total assets | $141.6M | $140.9M | $115.8M | $116.9M | $141.2M |
| Total liabilities | $115.3M | $109.1M | $81.6M | $59.8M | $56.0M |
| Shareholders' equity | $26.2M | $31.8M | $34.2M | $57.1M | $85.2M |
Source: SEC EDGAR filings · CIK 0001227636 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.